Cat is considered as beloved pet and a common source of allergens. Cat allergens are allergic to human and are generally found in cat saliva and are identified as glycoproteins. Most common allergen (glycoprotein) secreted by cat includes Fel d 1 (secreted by sebaceous gland) and Fel d 4 (secreted from cat saliva).
Most common symptoms of allergic reaction to cat includes watering eyes, sneezing, chapped lips, wheezing, chest tightening, nasal congestion, and itching.
National Institute of Health stated that people with chronic respiratory disease (asthma, COPD, CFTR) are at a high risk for developing cat allergy. Cat allergies can be diagnosed by skin-prick tests, blood tests and patient’s medical history.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/21235
As mentioned above, people with chronic respiratory disease are at high risk for developing cat allergies. Thus, with rising chronic respiratory disease patients the global market for cat allergy treatment is also experiencing significant growth worldwide.
As an instance, emphysema (COPD) and asthma are considered major factors that can cause cat allergy among the global population at a significant rate.
According to the Centers for Disease Control and Prevention (CDC), in 2012, North America accounted for the highest number of COPD cases in the world. The American Academy of Allergy, Asthma, and Immunology, estimated in 2012 that, more than 100 million people would suffer from asthma across the world by 2025.
Thus, rising prevalence of respiratory disorders would accentuate the global market demand of cat allergy treatment.
For the entire list of market players, request for Table of Content here @ https://www.persistencemarketresearch.com/toc/21235
North America and Europe was observed to be the largest cat allergy treatment market due to high prevalence rate of cat allergy reported in these regions. Moreover, technological improvement in diagnostic test and strong demand of diagnostic test would also account for the market growth in these regions. In addition, favorable initiatives taken by federal government also accounted for cat allergy treatment market growth in North American and European region.
Similarly, Asia-Pacific is considered as an untapped market due to lack of proper diagnostic facilities in some Asian countries (India, Pakistan, Bangladesh and Afghanistan). Asian market growth will be fuelled by the presence of untapped opportunities due to extensive increase in healthcare infrastructure.
Pre-Book Right Now for Exclusive Analyst Support @ https://www.persistencemarketresearch.com/checkout/21235
Similarly, Asia-Pacific is considered as an emerging market due to growing market penetration in this region. Rest of the world (RoW) holds fourth position in the global cat allergy treatment market due to poor economic and health condition in most of the African countries.
Major market players involved in manufacturing the therapeutic treatment product of cat allergy and contributing the global market share includes Glaxo SmithKline plc, Bristol Meyers Squibb, Aventis Pharmaceuticals, Pharmacia Upjohn Co., and Merck & Co. among others.
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com